Trump rescinded Executive Order 14087, "Lowering Prescription Drug Costs for Americans," which directed Medicare and Medicaid ...

MA plans are substantially overpaid compared to traditional Medicare. Much of these overpayments benefit the MA plans rather ...

Ozempic and Wegovy, the blockbuster but costly GLP-1 drugs often used for weight loss, are among the 15 medications that will ...

Medicare has chosen 15 prescription medications for price negotiations this year, building off a first round of negotiations ...

The 15 drugs selected for negotiation are prescribed to 5.3 million Medicare beneficiaries to treat conditions ranging from ...

Novo Nordisk expects Ozempic, which has been on the market since 2017, will be on Medicare's list of drugs to negotiate ...

Medicare will begin capping prescription drug costs at $2,000 annually from January 1—a move that's widely expected to ...

Medicare recipients who take expensive prescriptions will get a break this year with a $2,000 cap on drug costs.

The Biden administration announced Friday that Ozempic, Wegovy and 13 additional drugs will now be covered under Medicare ...

Although Medicare enrollees typically don't pay a premium for Part A, which covers hospital care, there's a cost for being ...

This past year featured key developments in the prescription drug policy area, including the implementation of significant ...

The AARP report suggests the spending cap could be huge for Medicare enrollees who take costly drugs for cancer, rheumatoid ...